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Abstract 
Aims: Spindle cell differentiation is not an uncommon finding in common acquired naevi and 
may represent a form of neurotisation with Schwannian differentiation of melanocytes. 
Perineurial differentiation in this context appears to be distinctly rare and is only poorly 
documented in the literature. 
Methods and results: We have identified six melanocytic tumours showing spindle cell 
morphology and perineurial differentiation from routine and referral material. Clinical data 
and follow-up were obtained, and the histological and immunohistochemical features were 
analysed. The tumours affected middle aged adults (median: 48; range: 26-74 years) with a 
wide anatomical distribution and benign follow up (median: 13; range: 6 to 48 months). All 
tumours were nodular and circumscribed but asymmetrical with extension into deep dermis 
and superficial subcutis. A characteristic finding was a biphasic growth pattern with a 
lentiginous compound naevus in the superficial aspect and abrupt transition to a prominent 
nodular spindle cell proliferation in the deeper reaches. Spindle cells were bland and 
uniform and arranged singly and in short fascicles in a loose fibromyxoid stroma. In areas, a 
whorled arrangement of slender spindle cells with wavy nuclei was appreciated. Distinctive 
intratumoral hypocellular nodules and peripheral lymphoid aggregates were additional 
features. By immunohistochemistry, the spindle cells were mainly S100-positive 
melanocytes. In areas, S100-/EMA+ spindle cells showing co-expression of glut-1 and 
claudin-1 were closely admixed. 
Conclusion: This perineurial differentiation likely represents a rare and unusual form of 
neurotisation. The tumours are benign but may be mistaken for desmoplastic melanoma. 
Awareness and careful attention to the clinico-pathological and immunohistochemical 
features allows reliable separation. 
Keywords: Melanocytic, naevi, perineurial, desmoplastic, neurotisation. 
Introduction 
Neurotisation is a well-established phenomenon in melanocytic naevi 1-3. It is characterised 
by spindle cell morphology of dermal melanocytes showing Schwann cell and Meissnerian 
differentiation. In its extreme form neurotised naevi closely resemble a neurofibroma 1-3. 
EMA expression is distinctly unusual in melanocytic naevi 4, 5.  It has rarely been described in 
congenital and acquired naevi with prominent spindle cell differentiation 6, 7. Perineurial 
differentiation was reported in two acquired naevi with spindle cell differentiation (so called 
“perineuriomatous melanocytic naevi”) 8. These tumours show distinctive morphological 
features in addition to EMA expression as evidence of their perineurial differentiation. They 
are poorly studied but may be mistaken for desmoplastic melanoma 8. We now aim to 
further characterise the clinico-pathological features of this unique group of melanocytic 
tumours and provide helpful clues to allow separation from desmoplastic melanoma. 
Material and methods 
Between 2013 and 2017, six melanocytic naevi showing prominent spindle cell 
differentiation and EMA expression of the dermal component were encountered in the 
routine and referral practice of one of the authors (TB). Routine haematoxylin and eosin 
stained sections were reviewed and immunohistochemical studies were performed 
following standard protocols. The antibodies used, their dilutions and sources are provided 
in Table 1. Clinical follow-up was obtained from patient records. 
Results 
Clinical data 
All patients were adults with a median and mean age of 48 years (range: 26-74) and a male 
to female ratio of 2:1. The anatomic distribution was wide and included the trunk (abdomen 
and shoulder), the extremities (arm and thigh), the neck and the scalp. The clinical 
presentation was of a longstanding naevus, an atypical naevus or a firm papule. Recent 
change was noted in two cases and one patient had a personal history of a thin superficial 
spreading melanoma on the opposite leg.  The submitting diagnosis of the five referred 
cases was desmoplastic melanoma in three and neurotised naevus with perineurial 
differentiation in two cases. The clinical findings are summarized in Table 2. 
Follow-up 
Follow-up ranged from 6 to 48 months (median: 13, mean: 18). All patients were alive with 
no evidence of disease. Four tumours were completely removed at time of biopsy. Two 
tumours were initially partially sampled. One of these was treated by subsequent complete 
excision. There was no evidence of recurrence or metastasis. One patient was treated for a 
presumed diagnosis of desmoplastic melanoma. He had a negative re-excision and a 
negative axillary sentinel lymph node biopsy. 
Histological features 
All tumours were dermal based, well-circumscribed but asymmetrical (Fig. 1a and b). Three 
tumours showed additional extension into underlying adipose tissue (Fig. 1b). The measured 
tumour thickness ranged from 3 mm to 10 mm (median: 4.8). A biphasic growth pattern was 
evident and a pre-existing lentiginous compound naevus was present at least focally in the 
superficial aspect in all cases (Fig. 1c). The junctional component was lentiginous in two and 
lentiginous and nested in four cases. There was architectural atypia in one case but there 
was no cytological atypia or Pagetoid spread and no significant shoulder formation was 
observed. The associated naevic dermal component was located in superficial dermis. It was 
composed of bland ovoid to epithelioid melanocytes and showed no cytological atypia or 
mitotic activity (Fig. 1c). There was an abrupt transition to a more deeply seated larger 
spindle cell proliferation with well-circumscribed nodular outlines and a dumbbell shaped 
appearance in one case. This part comprised most of the dermal component and was 
composed of bland and uniform spindle cells arranged in short fascicles and embedded in a 
variably loose fibrous or myxoid stroma (Fig. 1d). In areas, the spindle cells showed slender 
wavy nuclei with a whorled growth pattern (Fig. 1e). The spindle cells showed no cytological 
atypia or mitotic activity. An additional finding was the presence of distinctive intralesional 
hypocellular fibrous nodules and bands, and in the periphery of the tumour scattered 
lymphoid aggregates were present (Fig. 1f). 
Immunohistochemistry 
S100 expression was seen in the junctional part and throughout the dermal components 
including the spindle cell area (Fig. 2a and b). Melan A was expressed in melanocytes of the 
junctional and dermal naevic compartments. Scattered spindle cells also showed melan A 
expression (Fig. 2c). In contrast, HMB-45 staining was confined to the junctional component. 
EMA expression was present in a subset of the dermal spindle cells highlighting the long 
bipolar cytoplasmic processes (Fig. 2d). These cells also expressed Glut-1 and less 
prominently claudin-1 (Fig. 2e and f). Double labelling with antibodies against S100 and EMA 
demonstrated that the EMA and S100 were expressed in distinct cellular subpopulations 
which appeared intimately associated (Fig. 3a and b). The Ki67 proliferative index was low. 
Discussion 
We report a group of benign acquired naevi with distinctive and reproducible histological 
features characterised by prominent spindle cell morphology and perineurial differentiation 
of the dermal component. These tumours appear to be genuinely rare. Only two such 
tumours are documented in the literature and the majority of cases in this study were 
encountered in the referral rather than routine diagnostic setting. Clinically, these naevi 
affect middle aged adults with a male predilection. They present as papules with a wide 
anatomical distribution and a predilection for areas with intermittent rather than chronic 
sun exposure. A longstanding history and recent change are frequent findings. The 
characteristic unifying histological features are the presence of a benign lentiginous 
compound naevus in the superficial aspect and a larger nodular spindle cell component in 
the deeper reaches. The spindle cells are bland and uniform, and in areas they show long 
biphasic cytoplasmic processes and wavy nuclei characteristic of perineurial cells. They are 
embedded in a loose fibromyxoid stroma with admixed distinctive hypocellular fibrous 
nodules and scattered peripheral lymphoid aggregates. 
The spindle cell differentiation observed in these naevi likely reflects extensive neurotisation 
in a longstanding naevus 6, 8. Neurotisation is not an infrequently encountered 
phenomenon, often seen in naevi of the head and neck area 3. Neurotised naevi are 
characterised by spindle cell differentiation of dermal melanocytes (so-called “type C 
melanocytes”). The melanocytes resemble Schwann cells, and Meissnerian differentiation 
may also be seen. In the more developed stages the appearances closely resemble a 
neurofibroma with loosely arranged spindled melanocytes in a fibromyxoid matrix. A subset 
of neurotised naevi show a prominent desmoplastic or sclerotic stromal reaction, so called 
‘desmoplastic naevi’ 9-13. The spindle cells retain S100 expression by immunohistochemistry. 
At least scattered melan A expression and the presence of a background of a conventional 
naevus at least focally are clues to the diagnosis. Perineurial differentiation is characterised 
by the presence of slender spindle cells with wavy nuclei and elongated bipolar cytoplasmic 
processes in a whorled arrangement as seen in perineurioma 14-18. Immunohistochemically, 
perineurial cells express EMA, Glut-1 and claudin-1 but they are negative for S100 14-16, 18. 
While claudin-1 expression has been reported also in a significant subset of melanocytic 
naevi and melanoma, EMA expression is distinctly rare 5, 6, 19-21. It appears to represent an 
unusual form of neurotisation observed in a small subgroup of neurotised naevi only 6-8. The 
dermal component of these tumours is composed predominantly of S100-positive spindled 
melanocytes and in areas, spindle cells with perineurial differentiation are closely admixed. 
The perineurial cells are characterized by EMA staining with co-expression of the other 
perineurial markers, claudin-1 and Glut-1. They are negative for S100 and form a distinct 
cellular compartment as appreciated on double labelling for S100 and EMA. The findings are 
analogous to those observed in hybrid schwannoma-perineurioma 22. 
The importance of describing this finding as a distinct entity is to increase awareness due to 
the resemblance with desmoplastic melanoma to spare the patient further extensive 
surgery and the psychological and social impact of a diagnosis of melanoma. This pitfall is 
reflected by the fact that there was a high index of suspicion for desmoplastic melanoma for 
the cases referred for a second opinion. In contrast to the naevi with perineurial 
differentiation, desmoplastic melanoma is a tumour of chronically and severely sun-
damaged skin with a predilection for the head and neck of the elderly 13, 23-27. It typically 
presents as larger and often indurated plaques. Histologically, it shows a diffusely infiltrative 
growth within dermis and subcutis, often with additional invasion into underlying skeletal 
muscle and fascia. The spindled tumour cells show at least a degree of cytological atypia and 
they induce a sclerotic stromal response. Furthermore, desmoplastic melanoma rarely arises 
from a pre-existing benign lentiginous compound naevus and melan A expression is rare 12. 
Increased Ki-67 staining in desmoplastic melanoma has been found helpful at least in the 
differentiation from other desmoplastic/sclerotic naevi 12, 13. The presence of peripheral 
lymphoid aggregates is not a good distinguishing feature as it may be seen in both 
desmoplastic melanoma and naevi with perineurial differentiation. Similarly, the expression 
of EMA is not unique to naevi with perineurial differentiation and has rarely been 
documented in desmoplastic melanoma 21.  
The differential diagnosis also includes other melanocytic tumours with spindle cell 
differentiation such as heavily neurotised naevi and desmoplastic naevi 9-11. The distinction 
is possible by demonstration of EMA expression but is of little clinical consequence in view 
of the benign behaviour of these tumours. Similarly, nerve sheath tumours enter the 
differential diagnosis. Neurofibroma, solitary circumscribed neuroma, perineurioma and 
hybrid schwannoma-perineurioma may resemble melanocytic naevi with perineurial 
differentiation. The main distinguishing factor is the presence of a more conventional 
compound naevus and at least focally retained melan A expression. Malignant peripheral 
nerve sheath tumour is exceptionally rare in the skin outside the clinical setting of 
neurofibromatosis-1. It is characterized by increased cellularity and more pronounced 
cytological atypia. 
In conclusion, we outline the clinical, histological and immunohistochemical characteristics 
of a distinct group of benign melanocytic naevi showing perineurial differentiation. Although 
these tumours show some overlapping histological features with desmoplastic melanoma, 
separation is possible using the constellation of clinical setting, histological clues and 
immunohistochemical phenotype. Awareness and recognition of these rare benign 
melanocytic tumours is important to avoid misdiagnosis as desmoplastic melanoma with 
implication for over treatment. 
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Figure legends 
Figure 1: The tumours are dermal based and relatively well-circumscribed. They have a 
biphasic appearance with a pre-existing conventional naevus in the superficial aspect and a 
spindle cell proliferation in the deeper reaches of the dermis. Also note the peripheral 
lymphoid aggregate (a). Extension into superficial subcutaneous adipose tissue may be seen. 
Also note the circumscription of the dumbbell-shaped dermal component (b). There is an 
abrupt transition of a conventional lentiginous compound naevus to the more deeply seated 
dermal spindle cell proliferation (c). The deeper dermal component is composed of bland 
and uniform spindle cells arranged in short bundles in a loose fibromyxoid stroma (d). In 
other areas, the tumour shows a whorled arrangement of spindle cells in a sclerotic fibrous 
stroma. There is no cytological atypia or mitotic activity (e). The presence of admixed 
intradermal hypocellular nodules and bands was a characteristic feature in all tumours (f). 
Figure 2: By immunohistochemistry, S100 is expressed strongly and diffusely throughout the 
tumour (a). In the deeper spindle cell component expression of S100 is retained (b) and 
there is scattered melan A staining (c). Perineurial differentiation is identified in dermal 
spindle cells by immunohistochemical staining for EMA (d), glut-1 (e) and claudin-1 (f). 
Figure 3: Double labelling for S100 (red) and EMA (brown) shows strong EMA expression in 
the deeper aspects of the tumour (a) and highlights that S100 and EMA expression is seen in 
different cellular compartments (b). 
Table 1. Immunohistochemistry (antibodies, dilution and sources) 
Antibody Dilution Sources 
Claudin-1 1:50 Zymed, So. San Francisco, CA 
EMA 1:800 Dako UK Ltd, Cambridge, UK 
GLUT1 1:1500 Epitomics, Burlingame, CA 
Ki67 (Mib-1) 1:100 Dako UK Ltd, Cambridge, UK 
Melan-A (A103) 1:75 Dako UK Ltd, Cambridge, UK 
S100 1:1500 Dako UK Ltd, Cambridge, UK 
Table 2. Clinical data and follow-up 
ANED : alive with no evidence of disease ; F/U : follow-up 
Case Age Sex Location F/U F/U period 
(months) 
1 36 M scalp ANED 6 
2 74 F arm ANED 6 
3 48 M thigh ANED 18 
4 55 M abdomen ANED 8 
5 47 F shoulder ANED 24 
6 26 M neck ANED 48 







